Skip to main content
SpringerLink
Log in

Prostatic Cancer: An Age-Old Problem

  • Chapter
The Underlying Molecular, Cellular and Immunological Factors in Cancer and Aging

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 330))

Abstract

During this year there will be approximately 30 thousand deaths due to prostatic cancer in the United States (1). This mortality rate makes prostatic cancer the second commonest fatal tumor in males of all ages in America (1). Besides a high annual mortality rate, prostatic cancer is now the most commonly diagnosed malignancy in males of all ages in the United States (1). These high annual incidence rates translate into the human reality that one of every 11 American white male will eventually develop clinical prostatic cancer during their lifetime (2). Rates for American black males are even higher such that the lifetime risk for cancer is one out of every 10 (3). In addition, the annual incidence rate of clinical prostatic cancer has increased steadily since 1930’s to the present time (4).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Boring, C., Squires, T. and Tong, T. Cancer Statistics — Cancer Journal for Clinicians 42:19–38, 1992.

    Article  CAS  Google Scholar 

  2. Seidman, H., Mushinski, M. H., Gelb, S. K. and Silverberg, E. Probabilities of eventually developing or dying of cancer: United States. Cancer Journal for Clinicians 35:36–56, 1985.

    Article  CAS  Google Scholar 

  3. Mettlin, G. Epidemiology of prostate cancer in different population groups. Clinics in Oncology 2:287–300, 1983.

    Google Scholar 

  4. Devesa, S. S. and Silverman, D. T. Cancer incidence and morbidity trends in the United States: 1935-1947. J. Natl. Cancer Inst. 60:545–571, 1978.

    PubMed  CAS  Google Scholar 

  5. Carter, H. B. and Isaacs, J. T. Experimental and theoretical basic for hormonal treatment of prostatic cancer. Seminars in Urology 4:262–268, 1988.

    Google Scholar 

  6. U.S. Bureau of the Census, Statistical Abstract of the United States 1989 (109th edition) Washington, DC, 1989.

    Google Scholar 

  7. Horm, J. and Sondik, E. Person-Years of life lost due to cancer in the United States 1970 and 1984. Am. J. Public Health 79:1490–1493, 1989.

    Article  PubMed  CAS  Google Scholar 

  8. Carter, H. and Coffey, D. Prostate cancer: The magnitude of the problem in the United States. In Coffey, D., Resnick, M., Dorr, F. et. al (eds): A Multidisciplinary Analysis of Controversies in the Management of Prostate Cancer. Plenum Press, New York, Pp. 1–9, 1988.

    Chapter  Google Scholar 

  9. Carter, H. B., Piantadosi, S. and Isaacs, J. T. Clinical evidence for and implications of the multistep development of prostate cancer. J. Urol. 143:742–746, 1990.

    PubMed  CAS  Google Scholar 

  10. Dhom, G. Classification and grading of prostatic carcinoma. Recent Results Cancer Res 60:14–26, 1977.

    Article  PubMed  Google Scholar 

  11. Hohbach, C. and Dhom, G. Pathology of prostatic cancer. Scand. J. Urol Nephrol 55:37, 1980.

    CAS  Google Scholar 

  12. Watanabe, H., Ohe, H., Inaba, T., Itakura, Y., Saitoh, M. and Nakao, M. A mobile mass screening unit for prostatic disease. Prostate 5:559, 1984.

    Article  PubMed  CAS  Google Scholar 

  13. Zhang, P., Cheng, S., Zhou, Y., He, A., Hu, J., Huang, S. General survey to detect prostatic disease in 1,165 aged males over 60. Chinese J. Geriat. 3:99, 1984.

    Google Scholar 

  14. Miller, G. J. Diagnosis of stage A prostate cancer in the People’s Republic of China. In: A Multidisciplinary Analysis of Controversies in the Management of Prostate Cancer. Edited by D. S. Coffey, M. I. Resnick, F. A. Door, and J. P. Karr. Plenum Press, New York. Pp. 17–24, 1988.

    Chapter  Google Scholar 

  15. Dunn, J. E. Cancer epidemiology in populations of the United States — with emphasis on Hawaii and California — and Japan. Cancer Res 35:3240, 1975.

    PubMed  CAS  Google Scholar 

  16. Haenszel, W. and Kurihara, M. Studies on Japanese migrants. I. Mortality for cancer and other diseases among Japanese in the United States. J. Natl Cancer Inst. 40; 43, 1968.

    PubMed  CAS  Google Scholar 

  17. Akazaki, K. and Stemmerman, G. N. Comparative study of latent carcinoma of the prostate among Japanese in Japan and Hawaii. J. Natl Cancer Inst. 50:1137, 1973.

    PubMed  CAS  Google Scholar 

  18. Raghavan, D. Non-hormone chemotherapy for prostate cancer: principles of treatment and application to the testing of new drugs. Seminars in Oncology 15:371–389, 1988.

    PubMed  CAS  Google Scholar 

  19. Scott, W.W., Menon, M. and Walsh, P.C. Hormonal therapy of prostatic cancer. Cancer 45:1929–1936, 1980.

    PubMed  CAS  Google Scholar 

  20. Schulze, H., Isaacs J.T. and Coffey, D. S. A critical review of the concept of total androgen ablation in the treatment of prostatic cancer. IN Murphy GP, Khoury S, Kuss R, Chatelain C, Denis L (eds). Prostate Cancer Part A: Research Endocrine Treatment, and Histopathology. Progress in Clinical and Biological Research Vol. 243A: pp. 1–19. Alan R. Liss, Inc., New York, 1987.

    Google Scholar 

  21. Smith, J. A., Eyse, H.J., Roberts, T. S. and Middleton, R. G. Transphenoidal hypophysectomy in the management of carcinoma of the prostate. Cancer 53:2385–2387, 1984.

    Article  PubMed  Google Scholar 

  22. Menon, M. and Walsh, P. C. Hormonal therapy for prostatic cancer. In Murphy GP (ed). Prostatic Cancer. Littleton, Mass, PSG Publ. Co., pp 175–200, 1979.

    Google Scholar 

  23. Lepor, H., Ross, A. and Walsh, P. C. The influence of hormonal therapy on survival of men with advanced prostatic cancer. J. Urol. 128:335–340, 1982.

    PubMed  CAS  Google Scholar 

  24. Prout, G. R., Leiman, B., Daly, J.J., Macloughlin, R. A., Griffin, P. P., Young, H. H. Endocrine changes after diethylstilbestrol therapy. Urology 7:148–155, 1976.

    Article  PubMed  CAS  Google Scholar 

  25. Sinha, A. A., Blackhard, C. E., Seal, U. S. A critical analysis of tumor morphology and hormone treatment in the untreated and estrogen treated responsive and refractory human prostatic carcinoma. Cancer 40:2836–2850, 1977.

    Article  PubMed  CAS  Google Scholar 

  26. Isaacs, J. T. and Coffey, D. S. Adaptation vs selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation as studied in the Dunning R-3327 H adenocarcinoma. Cancer Res 41:5070–5075, 1981.

    PubMed  CAS  Google Scholar 

  27. Isaacs, J. T. Cellular factors in the development of resistance to hormonal therapy. In Bruchovsky, N. and Goldie, J. (eds). Drug and Hormone Resistance in Neoplasia. Vol. 1. CRC Press, Boca Raton, Inc. Pp 139-156, 1982.

    Google Scholar 

  28. Ellis, W. J. and Isaacs, J. T. Effectiveness of complete vs partial androgen withdrawal therapy for the treatment of prostatic cancer as studied in the Dunning R-3327 system of rat prostatic carcinoma. Cancer Res 45:6041–6050, 1985.

    PubMed  CAS  Google Scholar 

  29. Redding, T. W. and Schally, A. V. Investigation of the combination of the agonist D-Trp-6-LHRH and the antiandrogen flutamide on the treatment of Dunning R-3327 H prostatic cancer model. The Prostate 6:219–232, 1985.

    Article  PubMed  CAS  Google Scholar 

  30. Kung, T.T., Mingo, G. G., Siegel, M. I., Watnick, A. S. Effect of adrenalectomy, flutamide and leuprolide on the growth of the Dunning R-3327 prostatic carcinomas. The Prostate 12:357–364, 1988.

    Article  PubMed  CAS  Google Scholar 

  31. Isaacs, J. T. The timing of androgen ablation therapy and/or chemotherapy in the treatment of prostatic cancer. The Prostate 5:1–18, 1984.

    Article  PubMed  CAS  Google Scholar 

  32. Isaacs, J. T. Relationship between tumor size and curability of prostate cancer by combined chemohormonal therapy. Cancer Res 49:6290–6294, 1989.

    PubMed  CAS  Google Scholar 

  33. Schulze, H., Isaacs, J. and Senge, T. Inability of complete androgen blockage to increase survival of patients with advanced prostatic cancer as compared to standard hormone therapy. J. Urol. 137:909–914, 1987.

    PubMed  CAS  Google Scholar 

  34. Helpap, B., Steins, R. and Bruhl, P. Autoradiographic in vitro investigations of prostatic tissue with C-14 and H-3 thymidine double labelling method. Beitr Pathol. Anal. Allgem. Path. 151:65–72, 1974.

    Article  CAS  Google Scholar 

  35. Meyer, J. S., Sufrin, G. and Martin, S. A. S. Proliferative activity of benign human prostate, prostatic adenocarcinoma and seminal vesicle evaluated by thymidine labeling. J. Urol. 128:1353–1356, 1982.

    PubMed  CAS  Google Scholar 

  36. Isaacs, J. T. Antagonistic effect of androgen on prostatic cell death. Prostate 5:545–558, 1984.

    Article  PubMed  CAS  Google Scholar 

  37. Kyprianou, N. and Isaacs, J. T. Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 122:552–562, 1988.

    Article  PubMed  CAS  Google Scholar 

  38. Wyllie, A. H., Kerr, J. F.R. and Currie. A. R. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:251–306, 1986.

    Article  Google Scholar 

  39. Kerr, J. F. R., Wyllie, A. H. and Currie, A. R. Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Brit. J. Cancer 26:239–257, 1972.

    Article  PubMed  CAS  Google Scholar 

  40. Bowen, I. D. and Lockshin, R. A. Cell Death in Biology and Pathology. London: Chapman and Hill, 1981.

    Book  Google Scholar 

  41. Wyllie, A. H. Glucocorticoid induces in thymocytes a nuclease-like activity associated with the chromatin condensation of apoptosis. Nature 284:555–556, 1980.

    Article  PubMed  CAS  Google Scholar 

  42. Umansky, S. R., Korol, B. A. and Nelipovich, P. A. In vivo DNA degradation in thymocytes of-irradiated or hydrocortisone-treated rats. Biochim. Biophys. Acta 655:9–17, 1981.

    Article  PubMed  CAS  Google Scholar 

  43. Wyllie, A. H., Kerr, J. F. R, Macaskill, I. A. M. and Currie, A. R. Adrenocortical cell deletion: the role of ACTH. J. Pathol. 111:85–94, 1973.

    Article  PubMed  CAS  Google Scholar 

  44. Cohen, J. J. and Duke, R. C. Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J. Immunol. 132:38–42, 1984.

    PubMed  CAS  Google Scholar 

  45. Wyllie, A. H., Morris, R. G., Smith, A. L., Dunlop, D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J. Pathol. 142:67–77, 1984.

    Article  PubMed  CAS  Google Scholar 

  46. Compton, M. M. and Cidlowski, J. A. Rapid in vivo effects of glucocorticoids on the integrity of rat lymphocyte genomic deoxyribonucleic acid. Endocrinology 118:38–45, 1986.

    Article  PubMed  CAS  Google Scholar 

  47. Kyprianou, N., English, H. F. and Isaacs, J. T. Activation of a Ca+2-Mg+2-dependent endonuclease as an early event in castration-induced prostatic cell death. The Prostate 13:103–118, 1988.

    Article  PubMed  CAS  Google Scholar 

  48. English, H. F., Kyprianou, N. and Isaacs, J. T. Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castration. The Prostate 15:233–250, 1989.

    Article  PubMed  CAS  Google Scholar 

  49. Kerr, J. F.R. and Searle, J. Deletion of cells by apoptosis during castrationinduced involution of the rat prostate. Virchow Archiv B 13:87–102, 1973.

    CAS  Google Scholar 

  50. Lesser, B. and Bruchovsky, N. The effects of testosterone, 5-dihydrotestosterone and adenosine 3’,5’-monophosphate on cell proliferation and differentiation in rat prostate. Biochim. Biophys. Acta 308:426–437, 1973.

    Article  PubMed  CAS  Google Scholar 

  51. Lee, C. Physiology of castration-induced regression of the rat prostate. Prog. Clin. Biol. Res. 75A:145–159, 1982.

    Google Scholar 

  52. Sanford, M. L., Searle, J. W. and Kerr, J. F. R. Successive waves of apoptosis in the rat prostate after repeated withdrawal of testosterone stimulation. Pathology 16:406–410, 1984.

    Article  Google Scholar 

  53. Stanisic, T., Sadlowski, R., Lee, C., Grayhack, J. T. Partial inhibition of castrationinduced ventral prostate regression with actinomycin D and cycloheximide. Invest. Urol. 16:19–22, 1978.

    PubMed  CAS  Google Scholar 

  54. Lee, C. and Sensibar, J. A. Protein of the rat prostate: synthesis of new proteins in the ventral lobe during castration-induced regression. J. Urol. 138:903–908, 1985.

    Google Scholar 

  55. Salzman, A. G., Hiipakka, R. A., Chang, C., Liao, S. Androgen repression of the production of a 29 kilodalton protein and its mRNA in the rat ventral prostate. J. Biol. Chem. 262:432–437, 1987.

    Google Scholar 

  56. Montpetit, M. L., Lawless, K. R. and Tenniswood, M. Androgen repressed messages in the rat ventral prostate. The Prostate 8:25–36, 1986.

    Article  PubMed  CAS  Google Scholar 

  57. Buttyan, R., Zaker, Z., Lockshin, R. and Wolgemuth, D. Cascade induction of c-fos, c-myc and heat shock 70K transcripts during regression of the rat ventral prostate gland. Mol. Endocrinol. 2:650–657, 1988.

    Article  PubMed  CAS  Google Scholar 

  58. Kyprianou, N. and Isaacs, J. T. Expression of transforming growth factor-B in the rat ventral prostate during castration-induced programmed cell death. Mol. Endocrinol. 3:1515–1522, 1989.

    Article  PubMed  CAS  Google Scholar 

  59. Connor, J., Sawdzuk, I. S., Benson, M. C., Tomashersky, P., OTool, K. M., Olsson, C. A. and Buttyan, R. Calcium channel antagonists delay regression of androgen-dependent tissues and suppress gene activity associated with cell death. The Prostate 13:119–130, 1988.

    Article  PubMed  CAS  Google Scholar 

  60. Viskochil, D. H., Perry, S. T., Lea, D. A., Stafford, D. W., Wilson, E. M., French, E S. Isolation of two genomic sequences encoding the mr ∼ 1400 subunit of rat prostatein. J. Biol. Chem. 258:8861–8866, 1983.

    PubMed  CAS  Google Scholar 

  61. Martikainen, P. and Isaacs, J. T. An organ culture system for the study of programed cell death in the rat ventral prostate. Endocrinology 127:1258–1267, 1990.

    Google Scholar 

  62. Martikainen, P. and Isaacs, J. T. Role of calcium in the programmed death of rat prostatic glandular cells. The Prostate 17:175–187, 1991.

    Article  Google Scholar 

  63. Kyprianou, N., English, H., and Isaacs., J. T. Programmed cell death during regression of PC-82 human prostatic cancer. Cancer Res. 50:3748–3753, 1990.

    PubMed  CAS  Google Scholar 

  64. van Steenbrugge, G. J., Groen, M., Romijn, J. C. and Schroder. E Biological effects of hormonal treatment regimens on the transplantable human prostate tumor line (PC-82). J. Urol. 131:812–817, 1984.

    PubMed  Google Scholar 

  65. Kyprianou, N. and Isaacs, J. T. Thymine-less death in androgen-independent prostatic cancer cells. Biochem. Biophys. Res. Comm. 165:73–81, 1989.

    Article  PubMed  CAS  Google Scholar 

  66. Tucker, R. W., Meade-Cobun, K., Loats, H. Measurement of free intracellular calcium (Ca) in fibroblasts. Digital image analysis of Fura 2 fluorescence. In Fiskum, G. (ed), Plenum Publ. Corp. Pp 239-248, 1989.

    Google Scholar 

  67. Martikainen, P., Kyprianou, N., Tucker, R. W. and Isaacs, J. R. Programmed death of nonproliferating androgen-independent prostatic cancer cells. Cancer Research 51:4693–4700, 1991.

    PubMed  CAS  Google Scholar 

  68. Bettuzzi, S., HYiipakka, R. A., Gilna, P., Liao, S. Identification of an androgenrepressed mRNA in rat ventral prostate as coding for sulphated glycoprotein 2 by cDNA cloning and sequence analysis. Biochem. J. 257:293–296, 1989.

    PubMed  CAS  Google Scholar 

  69. Sylvester, S. R., Skinner, M. K. and Griswold, M. D. A sulfated glycoprotein synthesized by Sertoli cell and by epididymal cells is a component of the sperm membrane, Biol. Reproduc. 31:1087–1101, 1984.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Johns Hopkins Oncology Center and the Department of Urology, The Johns Hopkins School of Medicine, Baltimore, Maryland, 21231, USA

    John T. Isaacs

Authors
  1. John T. Isaacs
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. National Cancer Institute, Bethesda, Maryland, USA

    Stringner Sue Yang Ph.D.

  2. National Institute on Aging, Bethesda, Maryland, USA

    Huber R. Warner Ph.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media New York

About this chapter

Cite this chapter

Isaacs, J.T. (1993). Prostatic Cancer: An Age-Old Problem. In: Yang, S.S., Warner, H.R. (eds) The Underlying Molecular, Cellular and Immunological Factors in Cancer and Aging. Advances in Experimental Medicine and Biology, vol 330. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2926-2_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-2926-2_13

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6270-8

  • Online ISBN: 978-1-4615-2926-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation